Fig. 3: BMP4 acts via the SMAD pathway in progenitor Leydig cells (PLCs) in vitro. | Cell Death & Disease

Fig. 3: BMP4 acts via the SMAD pathway in progenitor Leydig cells (PLCs) in vitro.

From: Bone morphogenetic protein 4 inhibits rat stem/progenitor Leydig cell development and regeneration via SMAD-dependent and SMAD-independent signaling

Fig. 3

A Western blot. B Quantitative protein levels of pSMAD1/5, SMAD1/5, and their ratio; Mean ± SEM, n = 3. C Quantitative levels of SMAD4; Mean ± SEM, n = 5. D Western blot for Co-P proteins; E Quantitative data of Co-IP protein levels, Mean ± SEM, n = 6. *P < 0.05 and **P < 0.01 indicate significant differences compared to control (0 ng/mL BMP4).

Back to article page